Simson Jake 4
4 · Bicara Therapeutics Inc. · Filed Jun 10, 2025
Insider Transaction Report
Form 4
Simson Jake
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-09+23,746→ 23,746 totalExercise: $11.48Exp: 2035-06-09→ Common Stock (23,746 underlying)
Footnotes (2)
- [F1]This option was awarded to the reporting person pursuant to the Issuer's 2024 Stock Option and Incentive Plan. The shares underlying this option shall vest upon the earlier of (i) June 9, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the R.A. Capital Healthcare Fund, L.P. (the "Fund") and R.A. Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund III to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.